Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Monitoring the effectiveness of anticoagulation control.
-
Publication Type:Journal article
-
Publication Sub Type:Journal Article
-
Authors:Utley M, Patterson D, Gallivan S
-
Publication date:2005
-
Pagination:7, 14
-
Journal:Int J Health Care Qual Assur Inc Leadersh Health Serv
-
Volume:18
-
Issue:1
-
Status:Published
-
Country:England
-
Print ISSN:1366-0756
-
Language:eng
-
Keywords:Ambulatory Care, Anticoagulants, Drug Monitoring, Humans, International Normalized Ratio, Quality Assurance, Health Care, Treatment Outcome, United Kingdom
-
Author URL:
Abstract
PURPOSE: To assess the quality of anticoagulation control at an out-patient clinic and to investigate patterns of deviation from therapeutic ranges. DESIGN/METHODOLOGY/APPROACH: Records for 36,157 clinic visits (2050 patients) were studied. The quality of anticoagulation control was assessed by comparing the measurement of pro-thrombin time recorded at each clinic visit, expressed as an international normalised ratio (INR), with the target therapeutic range for that patient, also recorded at the time of the clinic visit. Each INR measurement was classified according to the relevant patient's therapeutic range and the signed difference between the INR measurement and the centre of the therapeutic range was calculated. For each patient the percentage of their INR measurements that lay within their therapeutic range was calculated. FINDINGS: Of the measurements, 52.3 per cent were within the relevant therapeutic range. The proportion of individual patients' INR measurements within range varied greatly (median 52 per cent, inter-quartile range 40-65 per cent). The quality of anticoagulation control, as measured by the proportion of patients within their therapeutic range, changed little with patient follow-up time. ORIGINALITY/VALUE: The quality of anticoagulation control reported is comparable with that at other centres. The vast majority of patients spend periods outside the therapeutic range for their condition. There may be considerable room for improvement.
› More search options
UCL Researchers